Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

17.11
Delayed Data
As of 4:02pm ET
 -0.08 / -0.47%
Today’s Change
15.22
Today|||52-Week Range
51.51
-52.80%
Year-to-Date
Teva/Nuvelution to Speed Up Development of Austedo in US
11:08am / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO
Sep 15 / Zacks.com - Paid Partner Content
S&P 500 and Dow Score Records With Wall Street Upbeat Ahead of Fed
Sep 18 / TheStreet.com - Paid Partner Content
Teva's Leukemia Drug sNDA Granted Priority Review by the FDA
Sep 13 / Zacks.com - Paid Partner Content
S&P 500 and Dow on Track for Records With Markets in Good Mood Ahead of Fed
Sep 18 / TheStreet.com - Paid Partner Content
Company News For Sep 13, 2017
Sep 13 / Zacks.com - Paid Partner Content
Dow and S&P 500 Reach New Intraday Highs With Markets in Good Mood Ahead of Fed
Sep 18 / TheStreet.com - Paid Partner Content
Teva's New CEO Brings No Relief: Generic Drugmakers to Dump
Sep 12 / Zacks.com - Paid Partner Content
Oncology Space in Focus this Week on ESMO Presentations
Sep 15 / Zacks.com - Paid Partner Content
Company News For Sep 12, 2017
Sep 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close17.19
Today’s open17.25
Day’s range16.96 - 17.54
Volume16,367,070
Average volume (3 months)16,882,736
Market cap$17.4B
Dividend yield6.46%
Data as of 4:02pm ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)-96.18%
Earnings growth (this year)-16.04%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+12.01%
P/E ratioNM
Price/Sales1.59
Price/Book0.59

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+1.11+1.30%
TYMETyme Technologies In...-0.20-3.51%
OASMOasmia Pharmaceutica...-0.07-6.52%
Data as of 3:59pm ET, 09/20/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$1.08
Annual revenue (last year)$22.0B
Annual profit (last year)$330.0M
Net profit margin1.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President &
Chief Executive Officer
Kåre Schultz
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts